Data Cart

Your data extract

0 variables
0 samples
View Cart



NATIONAL SURVEY ON MALARIA ("ENPS, 2008")
WOMAN'S QUESTIONNAIRE

Republic of Senegal
Ministry of Health and Medical Prevention

Macro International
Research Center for Human Development ("CRDH")

IDENTIFICATION

REGION______
HEALTH DISTRICT ______
DISTRICT MUNICIPALITY/RURAL COMMUNITY ______
CLUSTER NUMBER ______
NAME OF HEAD OF CONCESSION ______
NAME OF HEAD OF HOUSEHOLD ______
HOUSEHOLD NUMBER IN SAMPLE ______
NAME OF LOCALITY (DISTRICT MUNICIPALITY IN DAKAR, MUNICIPALITY, RURAL COMMUNITY) ______
URBAN/RURAL (URBAN = 1, RURAL = 2) ENVIRONMENT ______
DAKAR/REGIONAL CAPITAL/OTHER CITY/RURAL
(DAKAR = 1, REGIONAL CAPITAL = 2, OTHER CITY = 3, RURAL = 4) DETAILED ENVIRONMENT ______
NAME AND LINE NUMBER OF WOMAN ______
HOUSEHOLD SAMPLE (OF THE 30 IN CLUSTER)? (YES = 1, NO = 2) ______
HOUSEHOLD CHOSEN FOR ANEMIA/MALARIA TEST? (YES = 1, NO = 2) ______

INTERVIEWER VISITS

(Repeat up to 3 visits)

DATE ______
NAME OF INTERVIEWER ______
RESULT ______

NEXT VISIT:
DATE ______
TIME ______

FINAL VISIT
DAY ______
MONTH ______
YEAR 200______
INTERVIEWER NUMBER______
RESULT CODE ______

TOTAL NUMBER OF VISITS ______

RESULT CODES:
1 COMPLETED
2 NOT HOME
3 POSTPONED
4 REFUSED
5 PARTLY COMPLETED
6 INCAPACITATED
8 OTHER (SPECIFY) ______

LANGUAGE OF QUESTIONNAIRE 1
LANGUAGE OF INTERVIEW ______

LANGUAGE CODES:
1 FRENCH
2 WOLOF
3 PULAR
4 SERER
5 MANDINKA
6 DIOLA
8 OTHER

INTERPRETER (YES = 1, NO = 2) ______

TEAM LEADER
NAME ______
DATE ______

SUPERVISOR
NAME ______
DATE ______

OFFICE EDITOR ______

KEYED BY ______

SECTION 1. SOCIODEMOGRAPHIC BACKGROUND OF RESPONDENT

INTRODUCTION AND CONSENT REQUEST

INFORMED CONSENT
Hello. My name is ______ and I am working for the Ministry of Health. We are carrying out a national survey of malaria. We would like you to participate in this survey. The information you give us will be useful to the government for planning health services. The interview usually takes between 10 and 20 minutes. The information that you provide us will remain strictly confidential and will not be shared with anyone other than members of our survey.

Participation in this survey is voluntary and if there is a question you do not wish to answer, let me know and I will go on to the next question. You can also stop the interview at any time. However, we hope that you will accept to participate in this survey because your opinion is very important to us.

Do you have any questions about the survey?
May I begin the interview now?

Interviewer's signature: ______
Date: ______

1 RESPONDENT AGREES TO ANSWER (Continue to 101)
2 RESPONDENT DECLINES TO ANSWER QUESTIONS (Skip to END)

101. RECORD TIME.

HOUR ______
MINUTES ______

102. How long have you been living on an ongoing basis in (NAME OF CURRENT CITY/TOWN OF RESIDENCE)?

IF LESS THAN ONE YEAR, RECORD '00' YEAR.

YEARS ______
95 ALWAYS (Skip to 104)
96 VISITOR (Skip to 104)

103. Just before moving here, were you living in a big city, town, or in a village?

1 BIG CITY
2 TOWN
3 RURAL

104. In what month and year were you born?

MONTH ______
98 DK MONTH
YEAR ______
9998 DK YEAR

105. How old were you on your last birthday?

COMPARE AND CORRECT 104 AND/OR 105 IF INCONSISTENT.

AGE IN COMPLETE YEARS ______

106. Have you ever attended school?

1 YES
2 NO (Skip to 110)

107. What is the highest level of studies you attended: primary, secondary, or higher?

1 PRIMARY
2 SECONDARY
3 HIGHER

108. What is the last (YEAR/GRADE) you completed at this level?

YEAR ______

109. CHECK 107:

PRIMARY ______ (Continue to 110)
SECONDARY OR HIGHER ______ (Skip to 111)

110. Now I would like you to read this sentence out loud to me; read as much as you can.

SHOW CARD TO RESPONDENT.

IF RESPONDENT CANNOT READ THE WHOLE SENTENCE, PROBE:
Can you read part of the sentence?

1 CANNOT READ AT ALL
2 CAN READ PARTS OF THE SENTENCE
3 CAN READ ENTIRE SENTENCE
4 NO CARD IN RESPONDENT'S LANGUAGE (SPECIFY LANGUAGE) ______
5 BLIND/VISUALLY IMPAIRED

111. What is your religion?

1 MUSLIM
2 CHRISTIAN
3 ANIMIST
4 WITHOUT RELIGION
6 OTHER (SPECIFY) ______

112. Are you Senegalese?

1 YES
2 NO (Skip to 201)

113. What is your ethnicity?

01 WOLOF
02 PULAR
03 SERER
04 MANDINKA/SOCE
05 DIOLA
06 SONINKE/SARAKOLE
96 OTHER (SPECIFY) ______

SECTION 2. REPRODUCTION

201. Now I would like to ask you some questions about all the births you have had in your lifetime. Have you ever given birth?

1 YES
2 NO (Skip to 206)

202. Do you have any sons or daughters to whom you gave birth who are currently living with you?

1 YES
2 NO (Skip to 204)

203. How many sons live with you?
How many daughters live with you?

IF NONE, RECORD '00'.

SONS AT HOME ______
DAUGHTERS AT HOME ______

204. Do you have any sons or daughters to whom you gave birth who are still living but do not live with you?

1 YES
2 NO (Skip to 206)

205. How many sons are living but do not live with you?
How many daughters are living but do not live with you?

IF NONE, RECORD '00'.

SONS ELSEWHERE ______
DAUGHTERS ELSEWHERE ______

206. Have you ever given birth to a boy or girl who was born alive but who later died?

IF NO, PROBE: No baby who cried or showed other signs of life at birth but who did not survive?

1 YES
2 NO (Skip to 208)

207. How many boys died?
How many girls died?

IF NONE, RECORD '00'.

DECEASED BOYS ______
DECEASED GIRLS ______

208. TOTAL UP THE ANSWERS TO 203, 205, AND 207 AND RECORD THE TOTAL.
IF NONE, RECORD '00'.

TOTAL ______

209. CHECK 208:

I would like to be sure I understood correctly: you have had a TOTAL of ______ births in your life. Is that correct?

YES ______ (Continue to 210)
NO ______ PROBE AND CORRECT 201 - 208 AS NECESSARY

210. CHECK 208:

ONE OR MORE BIRTHS ______ (Continue to 211)
NONE ______ (Skip to 225)

211. Now I would like to make a list of all your births, whether they are still alive or not, starting with the 1st one that you had.
RECORD THE NAME OF ALL BIRTHS IN Q.212. RECORD TWINS/TRIPLETS ON SEPARATE LINES.
(IF MORE THAN 12 BIRTHS, USE AN ADDITIONAL QUESTIONNAIRE).

(Repeat questions 212 - 221 for up to 12 births)

212. What name was given to your (first/next) child?

01 (NAME) ______

213. Is (NAME) a single or multiple birth?

1 SINGLE
2 MULTIPLE

214. Is (NAME) a boy or a girl?

1 BOY
2 GIRL

215. In what month and year was (NAME) born?

PROBE: What is his/her birthdate?

MONTH ______
YEAR ______

216. Is (NAME) still alive?

1 YES
2 NO (Go to 220)

217. IF ALIVE:
How old was (NAME) on his/her last birthday?

RECORD AGE IN COMPLETED YEARS.

AGE IN YEARS ______

218. IF ALIVE:
Does (NAME) live with you?

1 YES
2 NO

219. IF ALIVE:
RECORD CHILD'S LINE NUMBER FROM HOUSEHOLD SCHEDULE
(RECORD '00' IF CHILD IS NOT LISTED IN HOUSEHOLD)

LINE NUMBER ______ (Skip to NEXT BIRTH)

220. IF DECEASED:

How old was (NAME) when he/she died?

IF '1 YEAR', PROBE:
How old was (NAME) in months?
RECORD IN DAYS IF LESS THAN ONE MONTH; IN MONTHS IF LESS THAN 2 YEARS; OR IN YEARS.

1 DAYS ______
2 MONTHS ______
3 YEARS ______

221. Were there other live births between (NAME OF PRECEDING BIRTH) and (NAME)? Including babies who died after birth?

1 YES
2 NO

222. Have you had other live births since the birth of (NAME OF LAST BIRTH)?
IF YES, RECORD IN BIRTH TABLE.

1 YES
2 NO

223. COMPARE 208 WITH NUMBER OF BIRTHS RECORDED IN THE TABLE ABOVE AND CHECK OFF:

NUMBERS ARE EQUAL ______ (Go to CHECK)
CHECK: FOR EACH BIRTH: YEAR OF BIRTH IS RECORDED. ______
FOR EACH LIVING CHILD: CURRENT AGE IS RECORDED. ______
FOR EACH DECEASED CHILD: AGE AT TIME OF DEATH IS RECORDED. ______
FOR AGE AT TIME OF DEATH 12 MONTHS OR 1 YEAR: PROBE TO DETERMINE THE EXACT NUMBER OF MONTHS. ______

NUMBERS ARE DIFFERENT ______ (PROBE AND CORRECT)

224. CHECK 215 AND RECORD THE NUMBER OF BIRTHS IN 2003 OR LATER.
IF NONE, RECORD '0'.
______

225. Are you pregnant now?

1 YES
2 NO (Skip to 226A)
8 UNSURE (Skip to 226A)

226. How many months pregnant are you?

RECORD THE NUMBER OF COMPLETED MONTHS.

MONTHS ______
98 DK

226A. In your opinion, what are the benefits for a pregnant woman to sleep under a mosquito net soaked in insecticide?

A NO BENEFITS
B MORE EFFECTIVE AGAINST MOSQUITOS
C KILLS MOSQUITOS/OTHER INSECTS
D ELIMINATES MOSQUITOS/OTHER INSECTS
E BETTER FOR PREVENTING MALARIA
F BETTER FOR PREVENTING MISCARRIAGES/STILLBIRTHS
G WOMAN BETTER PROTECTED AGAINST ILLNESSES
H SAVES MONEY BECAUSE CHILD IS NOT SICK
X OTHER (SPECIFY) ______
Z DK

226B. In your opinion, what are the disadvantages for a pregnant woman to sleep under a mosquito net soaked in insecticide?

A NO DISADVANTAGES
B BAD SMELL
C CAUSES IRRITATIONS/COUGH
D MAKES SICK
E MAKES NAUSEOUS
F PRODUCES DANGEROUS CHEMICAL
G PRODUCT USED CAN KILL FETUS/CAUSE MISCARRIAGE
H CAN SUFFOCATE/RESPIRATORY DIFFICULTIES
I INSECTICIDE USED NOT EFFECTIVE
J MOSQUITO NET GETS DIRTY QUICKLY
X OTHER (SPECIFY) ______
Z DK

227. CHECK 224:

ONE OR SEVERAL BIRTHS IN 2003 OR LATER ______ (Continue to 301)
NO BIRTHS IN 2003 OR LATER ______ (Skip to 435)

SECTION 3. PREGNANCY AND INTERMITTENT PREVENTIVE TREATMENT

301. RECORD NAME AND SURVIVORSHIP OF LAST BIRTH IN 302.
Now I would like to ask you some questions about your last pregnancy that ended in a live birth, in the last 6 years (2003 or later).

302. CHECK 212 FOR NAME AND LINE NUMBER.
CHECK 216 FOR SURVIVORSHIP STATUS OF CHILD.

LAST BIRTH:
NAME: ______
LINE NUMBER ______
LIVING: ______ (Continue to 303)
DECEASED: ______ (Continue to 303)

303. When you were pregnant with (NAME) did you receive any antenatal care?

IF YES: Whom did you see?
Anyone else?

PROBE TO DETERMINE TYPE OF PERSON AND RECORD ALL PEOPLE SEEN.

HEALTH PROFESSIONAL
A DOCTOR
B MIDWIFE
C NURSE/HEAD NURSE

OTHER PERSON
D VILLAGE MIDWIFE "MATRONNE"
E TRADITIONAL BIRTH ATTENDANT
F RELATIVE/FRIEND
X OTHER (SPECIFY) ______
Y NO ONE

304. During this pregnancy, did you take any medicine to prevent malaria?

1 YES
2 NO (Skip to 401)
8 UNSURE/DK (Skip to 401)

305. What medication did you take?

RECORD ALL MENTIONED.

IF TYPE OF MEDICATION CANNOT BE DETERMINED, SHOW COMMON ANTIMALARIAL MEDICATIONS TO RESPONDENT.

A SP/FANSIDAR
B CHLOROQUINE
X OTHER (SPECIFY) ______
Z DK/NO ANSWER

[###translator's note: code Z "PDR" assumed to mean "pas de réponse", or "no answer"]

306. CHECK 305. MEDICATIONS TAKEN TO PREVENT MALARIA

CODE 'A' CIRCLED: ______ (Continue to 306A)
CODE 'A' NOT CIRCLED: ______ (Skip to 401)

306A. Did you get the (SP/Fansidar) medication for free, or did you pay money for it?

1 FREE (Skip to 307)
2 PAID MONEY

306B. How much money did you pay to get it?

RECORD IN CFA FRANCS.

PRICE ______
9998 DK

307. How many times did you take SP/Fansidar during this pregnancy?

NUMBER OF TIMES ______
98 DK/NO ANSWER

308. CHECK 303: ANTENATAL CARE PROVIDED BY A HEALTH PROFESSIONAL DURING THIS PREGNANCY?

CODE 'A', 'B', OR 'C' CIRCLED: ______ (Continue to 309)
OTHER: ______ (Skip to 401)

309. Did you get the SP/Fansidar at an antenatal appointment, at a different visit to a health center, or from another source?

1 ANTENATAL VISIT
2 OTHER HEALTH CENTER
6 OTHER SOURCE (SPECIFY) ______
8 DK/NO ANSWER

SECTION 4. FEVER IN CHILDREN.

401. RECORD THE LINE NUMBER, NAME, AND SURVIVORSHIP STATUS OF EACH BIRTH IN 2003 OR LATER IN THE TABLE. ASK THE QUESTIONS ABOUT EACH OF THESE BIRTHS. START WITH THE LAST BIRTH. (IF THERE ARE MORE THAN 3 BIRTHS, USE ANOTHER QUESTIONNAIRE, BEGINNING IN THE FIRST COLUMN).

Now I would like to ask you some questions about the health of all your children who are under the age of 6 (born in 2003 or later). (We will talk about one child at a time).

402. LINE NUMBER FROM 212

LAST BIRTH
LINE NUMBER ______

NEXT-TO-LAST BIRTH
LINE NUMBER ______

SECOND-TO-LAST BIRTH
LINE NUMBER ______

403. CHECK 212: RECORD THE NAME.
CHECK 216: RECORD SURVIVORSHIP STATUS.

NAME ______
LIVING ______ (Continue to 404)
DECEASED ______ (GO TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)

404. Did (NAME) have a fever at any time in the last two weeks?

1 YES
2 NO (RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)
8 DK (RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)

405. How many days ago did the fever start?

IF LESS THAN ONE DAY, RECORD '00'.

DAYS ______
98 DK

406. Did you seek out any advice or treatment for the fever from any source?

1 YES
2 NO (SKIP TO 411)

407. Where did you seek out advice or treatment?

Anywhere else?

PROBE TO IDENTIFY THE TYPES OF PLACES AND CIRCLE THE APPROPRIATE CODE(S).

IF UNABLE TO DETERMINE IF HOSPITAL, HEALTH CENTER, OR CLINIC IS A PUBLIC OR PRIVATE ESTABLISHMENT, RECORD THE NAME OF THE PLACE.
(NAME OF PLACE) ______

PUBLIC SECTOR
A GOVERNMENT HOSPITAL
B GOVERNMENT HEALTH CENTER
C GOVERNMENT RURAL HEALTH POST
D RURAL MATERNITY
E VILLAGE HEALTH CENTER
F COMMUNITY PHARMACY
G OUTREACH/MOBILE TEAM
H COMMUNITY HEALTH AGENT
I OTHER PUBLIC (SPECIFY) ______

PRIVATE MEDICAL SECTOR
J HOSPITAL/CLINIC/OFFICE
K PHARMACY
L PRIVATE DOCTOR
M RELIGIOUS DISPENSARY
N COMMUNITY HEALTH AGENT
O OTHER PRIVATE MEDICAL (SPECIFY) ______

OTHER SOURCE
P SHOP/MARKET
Q TRADITIONAL HEALER
R RELATIVE/FRIEND/NEIGHBOR

X OTHER (SPECIFY) ______

408. CHECK 407:

2 OR MORE CODES CIRCLED ______ (Continue to 409)
ONLY ONE CODE CIRCLED ______ (SKIP TO 410)

409. Where did you go first to seek advice or treatment?

USE LETTER CODE FROM 407.

1ST PLACE ______

410. How many days after the fever began did you start seeking out advice/treatment for (NAME)?
IF SAME DAY, RECORD '00'.

DAYS ______

410A. Besides the fever, what other symptoms did (NAME) have?

A CHILLS
B HEADACHE
C COUGH
D SPUTUM/NAUSEA
E SORE THROAT
F SKIN RASH
G DRAINAGE FROM EAR
H VOMITING
X OTHER (SPECIFY) ______

410B. When (NAME) had a fever, was he/she tested to see if he/she had malaria or not? The test consists of taking a few drops of blood from a finger or heel and analyzing it to know right away if (NAME) had malaria or not.
SHOW INSTRUMENTS USED.

1 YES
2 NO (Skip to 411)
8 DK (Skip to 411)

410C. Were you told the results of the test done on (NAME)?

1 YES
2 NO (SKIP TO 411)
8 DK (SKIP TO 411)

410D. What was the result of the malaria test done on (NAME)?

1 POSITIVE
2 NEGATIVE
8 DK

411. Does (NAME) still have a fever?

1 YES
2 NO
8 DK

412. Did (NAME) take any medication for the fever at any time?

1 YES
2 NO (RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)
8 DK (RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)

413. What medication did (NAME) take?

Other medications?

RECORD ALL MENTIONED.
ASK TO SEE THE MEDICATION(S) IF TYPE OF MEDICATION IS UNKNOWN.

IF TYPE OF MEDICATION CANNOT BE IDENTIFIED, SHOW COMMON ANTIMALARIAL MEDICATIONS TO THE RESPONDENT.

ANTIMALARIALS (1)
A ACT: FALCIMON
B OTHER ACT
C SP/FANSIDAR
D CHLOROQUINE
E AMODIAQUINE
F QUININE
G OTHER ANTIMALARIAL

OTHER MEDICATIONS
H ASPIRIN
I ACETAMINOPHEN/PARACETAMOL
J IBUPROFEN
X OTHER (SPECIFY) ______
Z DK

414. CHECK 413:
ANY CODE A - G CIRCLED?

YES ______ (Continue to 415)
NO ______ (RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)

415. Did you already have (NAME OF MEDICATION FROM 413) at home when (NAME) got sick?

ASK THE QUESTION SEPARATELY FOR EACH ANTIMALARIAL GIVEN IN 413.

IF YES, CIRCLE THE CODE FOR THIS MEDICATION.
IF NO FOR ALL MEDICATIONS, CIRCLE 'Y'.

ANTIMALARIALS (1)
A ACT: FALCIMON
B OTHER ACT
C SP/FANSIDAR
D CHLOROQUINE
E AMODIAQUINE
F QUININE
G OTHER ANTIMALARIAL
Y NO MEDICATION AT HOME

416. CHECK 413:

WAS ACT GIVEN ('A' OR 'B')?

CODES 'A' OR 'B' CIRCLED ______ (Continue to 417)
CODES 'A' AND 'B' NOT CIRCLED ______ (SKIP TO 419)

417. How soon after the beginning of the fever did (NAME) start taking tablets of amonate/falcimon/arsucam?

0 SAME DAY
1 NEXT DAY
2 TWO DAYS AFTER FEVER
3 THREE DAYS AFTER FEVER
4 FOUR OR MORE DAYS AFTER FEVER
8 DK

418. For how many days did (NAME) take the amonate/falcimon/arsucam tablets?

IF 7 OR MORE DAYS, RECORD '7'.

DAYS ______
8 DK

418A. Did you get the medication ('A' or 'B') for free, or did you pay money to get it?

1 FREE (SKIP TO 419)
2 PAID MONEY

418B. How much money did you pay to get it?

RECORD IN CFA FRANCS.

PRICE ______
9998 DK

419. CHECK 413.

WAS SP/FANSIDAR 'C' GIVEN?

CODE 'C' CIRCLED ______ (Continue to 420)
CODE 'C' NOT CIRCLED ______ (Skip to 422)

420. How soon after the beginning of the fever did (NAME) start taking SP/Fansidar?

0 SAME DAY
1 NEXT DAY
2 TWO DAYS AFTER FEVER
3 THREE DAYS AFTER FEVER
4 FOUR OR MORE DAYS AFTER FEVER
8 DK

421. For how many days did (NAME) take SP/Fansidar?

IF 7 OR MORE DAYS RECORD 7.

DAYS ______
8 DK

422. CHECK 413.

WAS CHLOROQUINE 'D' GIVEN?

CODE 'D' CIRCLED ______ (Continue to 423)
CODE 'D' NOT CIRCLED ______ (SKIP TO 425)

423. How soon after the beginning of the fever did (NAME) start taking chloroquine?

0 SAME DAY
1 NEXT DAY
2 TWO DAYS AFTER FEVER
3 THREE DAYS AFTER FEVER
4 FOUR OR MORE DAYS AFTER FEVER
8 DK

424. For how many days did (NAME) take chloroquine?

IF 7 OR MORE DAYS RECORD 7.

DAYS ______
8 DK

425. CHECK 413.

WAS AMODIAQUINE 'E' GIVEN?

CODE 'E' CIRCLED ______ (Continue to 426)
CODE 'E' NOT CIRCLED ______ (SKIP TO 428)

426. How soon after the beginning of the fever did (NAME) start taking amodiaquine?

0 SAME DAY
1 NEXT DAY
2 TWO DAYS AFTER FEVER
3 THREE DAYS AFTER FEVER
4 FOUR OR MORE DAYS AFTER FEVER
8 DK

427. For how many days did (NAME) take amodiaquine?

IF 7 OR MORE DAYS RECORD 7.

DAYS ______
8 DK

428. CHECK 413:

WAS QUININE 'F' GIVEN?

CODE 'F' CIRCLED ______ (Continue to 429)
CODE 'F' NOT CIRCLED ______ (SKIP TO 431)

429. How soon after the beginning of the fever did (NAME) start taking quinine?

0 SAME DAY
1 NEXT DAY
2 TWO DAYS AFTER FEVER
3 THREE DAYS AFTER FEVER
4 FOUR OR MORE DAYS AFTER FEVER
8 DK

430. For how many days did (NAME) take quinine?

IF 7 OR MORE DAYS RECORD 7.

DAYS ______
8 DK

431. CHECK 413:

WERE OTHER ANTIMALARIALS 'G' GIVEN?

CODE 'G' CIRCLED ______ (Continue to 432)
CODE 'G' NOT CIRCLED ______ (RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, SKIP TO 435)

432. How soon after the beginning of the fever did (NAME) start taking other antimalarials?

0 SAME DAY
1 NEXT DAY
2 TWO DAYS AFTER FEVER
3 THREE DAYS AFTER FEVER
4 FOUR OR MORE DAYS AFTER FEVER
8 DK

433. For how many days did (NAME) take other antimalarials?

IF 7 OR MORE DAYS RECORD 7.

DAYS ______
8 DK

434. RETURN TO NEXT COLUMN IN 403 OR IF NO MORE BIRTHS, CONTINUE TO 435.

435. RECORD TIME.

HOUR ______
MINUTES ______

Note: (1): LIST OF REGISTERED ACT IN SENEGAL

(Table)

Laboratory: CIPLA
Commercial name: Falcimon (Adult, adolescent child)
International non-proprietary name: Artesunate + amodiaquine

Laboratory: Sanofil/Aventis
Commercial name: Arsucam (Adult, adolescent child)
Coarsucam (Adult, adolescent child)
International non-proprietary name: Artesunate + amodiaquine

Laboratory: Mepha
Commercial name: Artéquin
International non-proprietary name: Artesunate + Mefloquine

Laboratory: IPCA
Commercial name: Larimal FD 400 B/3 and B/6
International non-proprietary name: Artesunate + amodiaquine

Laboratory: Dafra Pharma
Commercial name: Co Arinate FDC (Adult, adolescent child)
Co Artesiane syrup fl/120ml
International non-proprietary name: Artesunate + SP
Artemether + lumefantrine

Laboratory: GVC
Commercial name: Lonart syrup fl/60 ml
Lonart suppo B/6
International non-proprietary name: Artemether + lumefantrine
Artemether + lumefantrine

Laboratory: Pfizer
Commercial name: Camoquin plus (Adult, adolescent child)
Dualkin
International non-proprietary name: Artesunate + amodiaquine
Artesunate + amodiaquine

Laboratory: Novartis
Commercial name: Coartem
International non-proprietary name: Artemether + lumefantrine

Laboratory: Stallion
Commercial name: Kesunate
International non-proprietary name: Artesunate + amodiaquine

Laboratory: Macleodes
Commercial name: Lumiter
International non-proprietary name: Artemether + lumefantrine

Laboratory: EGR
Commercial name: Cofantrine B/24cp
Cofantrine syrup 2fl/60ml
Cofantrine suppo B/6
International non-proprietary name: Artemether + lumefantrine
Artemether + lumefantrine
Artemether + lumefantrine

Laboratory: Beo Pharma
Commercial name: Artemin
Arimal FD
Duocotexcin
P-Alaxin
Coartema
International non-proprietary name: Artemether
Artesunate + amodiaquine
Dihydroartemisine + piperaquine
Dihydroartemisine + piperaquine
Dihydroartemisine + piperaquine

OBSERVATIONS OF INTERVIEWER

TO BE FILLED OUT ONCE THE INTERVIEW IS FINISHED

COMMENTS ON THE RESPONDENT: ______

COMMENTS ON PARTICULAR QUESTIONS: ______

OTHER COMMENTS: ______

OBSERVATIONS OF TEAM LEADER
______

NAME OF TEAM LEADER: ______
DATE: ______